For instance, while EGCG (epigallocatechin gallate) alleviated obesity-driven lung cancer via STAT1/SLC7A11 signaling (73), its low bioavailability necessitates further optimization for therapeutic use. This evidence concerns the gene SLC7A11 and lung carcinoma.